Xintela AB (publ) Company
(COM)%20.jpg)
Xintela AB (publ), a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors.
Industry:
Biotechnology, Health Care, Science and Engineering
Investors Number:
3
Technology:
NeuroTech
Last Funding Type:
Venture - Series Unknown
Headquarters:
Lund, Skane Lan, Sweden
Founded Date:
2009-01-01
Investor Type:
For Profit
Total Funding:
SEK5M
Estimated Revenue:
Less than $1M
Employee Number:
11-50